Complication | No of patients (N=114), n (%) | Median days (IQR) |
Overall | 114 | 6.5 (5–9) |
No complications | 52 (45.6) | 6 (4–8) |
Temporary pacemaker wire not removed during procedure | 56 (49.1) | 6.5 (5–11.75) |
Complications | ||
Periprocedural myocardial infarction | 2 (1.7) | 13.50 (5–22) |
Spontaneous myocardial infarction | 0 | - |
TIA | 0 | - |
Minor stroke | 2 (1.7) | 6.50 (5–8) |
Major stroke | 0 | - |
Life-threatening bleeding | 0 | - |
Major bleeding | 2 (1.8) | 17 (6-28) |
Minor bleeding | 22 (19.3) | 6 (4.5–11.5) |
AKI stage I | 11 (9.6) | 12 (7-22) |
AKI stage II | 2 (1.7) | 13.50 (5-22) |
AKI stage III | 0 | - |
Major vascular complications | 0 (0.0) | - |
Minor vascular complications | 20 (17.5) | 7 (5–11) |
Hospital-related infection | 9 (7.8) | 8 (6.5–17.5) |
Pacemaker implantation | 5 (4.4) | 6.5 (4.5–46.75) |
Delirium | 5 (4.4) | 7 (4–25) |
AKI, acute kidney injury; TIA, transient ischaemic attack; VARC, Valve Academic Research Consortium.